Product References
E2F7 drives autotaxin/Enpp2 transcription via chromosome looping: Repression by p53 in murine but not in human carcinomas.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology
Lin KH,Lee SC,Dacheux MA,Norman DD,Balogh A,Bavaria M,Lee H,Tigyi G
Published figure using E2F7 polyclonal antibody (Product # PA5-68911) in Western Blot
Sat Jul 01 00:00:00 EDT 2023
Harnessing transcriptionally driven chromosomal instability adaptation to target therapy-refractory lethal prostate cancer.
Cell reports. Medicine
Dhital B,Santasusagna S,Kirthika P,Xu M,Li P,Carceles-Cordon M,Soni RK,Li Z,Hendrickson RC,Schiewer MJ,Kelly WK,Sternberg CN,Luo J,Lujambio A,Cordon-Cardo C,Alvarez-Fernandez M,Malumbres M,Huang H,Ertel A,Domingo-Domenech J,Rodriguez-Bravo V
PA5-68911 was used in Western Blotting and Immunohistochemistry to unveil a chromosomal instability (CIN) tolerance mechanism as a therapeutic vulnerability of therapy-refractory lethal prostate cancer.
Tue Feb 21 00:00:00 EST 2023
Harnessing transcriptionally driven chromosomal instability adaptation to target therapy-refractory lethal prostate cancer.
Cell reports. Medicine
Dhital B,Santasusagna S,Kirthika P,Xu M,Li P,Carceles-Cordon M,Soni RK,Li Z,Hendrickson RC,Schiewer MJ,Kelly WK,Sternberg CN,Luo J,Lujambio A,Cordon-Cardo C,Alvarez-Fernandez M,Malumbres M,Huang H,Ertel A,Domingo-Domenech J,Rodriguez-Bravo V
PA5-68911 was used in Western Blotting and Immunohistochemistry to unveil a chromosomal instability (CIN) tolerance mechanism as a therapeutic vulnerability of therapy-refractory lethal prostate cancer.
Tue Feb 21 00:00:00 EST 2023
MicroRNA-302a/d inhibits the self-renewal capability and cell cycle entry of liver cancer stem cells by targeting the E2F7/AKT axis.
Journal of experimental & clinical cancer research : CR
Ma YS,Lv ZW,Yu F,Chang ZY,Cong XL,Zhong XM,Lu GX,Zhu J,Fu D
PA5-68911 was used in Western Blotting to provide the first evidence that E2F7 is a direct target of miRNA-302a/d and miRNA-302a/d inhibits the stemness of LCSCs and proliferation of HCC cells by targeting the E2F7/AKT/Β-catenin/CCND1 signaling pathway.
Tue Oct 16 00:00:00 EDT 2018
MicroRNA-302a/d inhibits the self-renewal capability and cell cycle entry of liver cancer stem cells by targeting the E2F7/AKT axis.
Journal of experimental & clinical cancer research : CR
Ma YS,Lv ZW,Yu F,Chang ZY,Cong XL,Zhong XM,Lu GX,Zhu J,Fu D
PA5-68911 was used in Western Blotting to provide the first evidence that E2F7 is a direct target of miRNA-302a/d and miRNA-302a/d inhibits the stemness of LCSCs and proliferation of HCC cells by targeting the E2F7/AKT/Β-catenin/CCND1 signaling pathway.
Tue Oct 16 00:00:00 EDT 2018